Funding for this research was provided by:
Macquarie Group Foundation
National Health and Medical Research Council
Victorian Government Department of Jobs, Precincts and Regions
Received: 25 March 2022
Accepted: 14 September 2022
First Online: 23 September 2022
: This study (122/20) and the broader Optimise Study (333/20) were granted ethics approval by Alfred Hospital Ethics Committee as part of Alfred Health. All participants were advised that their participation was voluntary and each provided informed written consent to participate in the study.
: Not applicable.
: MH receives funding from Gilead Sciences and Abbvie for investigator initiated research. JD declares funding to his institution from Gilead Sciences and Abbvie for investigator initiated research and speaking fees. AC was previously Deputy Victorian Chief Health Officer (July 2020—June 2021) and was involved in quarantine policy during that time. The remaining authors declare that they have no competing interests.